Search

The article focuses on interplay between the cultural cargo carried by Jewish immigrants and of the culture of their neighbors and of broader American society and ethnic solidarity to Jewish merchants in the American cotton industry.

The article offers a case report of two women including a 16-year-old woman in labor died after accidental IV administration of fentaNYL with bupivacaine instead of penicillin G.3, and a 21-year-old woman in labor received IV fentaNYL with bupivacaine instead of penicillin G; and mentions that due to the risk of mix-ups between epidural analgesia and IV antibiotics in L&D settings, several recommendations are given including consider less toxic anesthetics, and conduct a time-out.

This section offers news briefs on medication errors as of December 2023. A carton of unfrozen ice pops labeled EMERPHED presumably as a product promotion by pharmaceutical company Nexus for its ePHEDrine sulfate injection was given to a hospital pharmacy department. Two vials of the Infuvite Adult multivitamin injection from Sandoz Canada with the same National Drug Codes and bar codes were used by a pharmacy technician to prepare an intravenous infusion.

This section offers news briefs on medication errors as of November 2023. The Fellows of the American Society of Health-System Pharmacists has called upon the U.S. Food and Drug Administration to require bar codes on immediate container labels and to incorporate the medication's lot number and expiration date. Confusion between the actual medication cartons and demonstration cartons of Ryanodex (dantrolene sodium) has been reported by a hospital.

A recent string of errors associated with tacrolimus, an immunosuppressant used primarily to prevent rejection in transplant recipients, prompted ISMP to review the literature and analyze related events reported to the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) and the ISMP National Medication Errors Reporting Program (MERP). We found that tacrolimus has been involved in many reported errors during the past decade that have been caused by a wide variety of factors, the most common of which are described below. [ABSTRACT FROM AUTHOR]

The article discusses the common missteps with medication safety. Topics include relying on a single risk-reduction strategy, strategies that will not prevent similar errors, and failing to address all causal factors. It also discusses the failure to measure the implementation and effectiveness of action plans. Recommendations to avoid the common missteps are presented.

The article discusses different cases of medication errors. These include the case of a patient who had been receiving wrong dose of amiodarone for recurrent hemodynamically unstable ventricular tachycardia (VT) and automated dispensing cabinet (ADC) drug description that leads to mannitol overdose.

The article presents news briefs about medication errors. The U.S. Food and Drug Administration (FDA) has approved the temporary importation by Qilu Pharmaceutical and its distributor Apotex of CISplatin from China to address the shortage of the drug. Also cited are the reports by some organizations of cases of mix-ups between the generic once-daily and twice-daily formulations of timolol maleate ophthalmic 0.5% solution from Bausch + Lomb.

The article presents different cases of medication errors. An anesthesiologist inadvertently administered lidocaine at a rate of 30mg/minute instead of 30 mcg/kg/minute and the patient received 1,500 mg over 50 minutes rather than the intended dose of 85 mg. A pharmacy technician identified a look-alike labeling concern upon receiving a shipment of Enfamil Poly-Vi-Sol multivitamin drops and Polyvisol multivitamin & iron drops manufactured by Mead Johnson & Company.

These medication errors have occurred in health care facilities at least once. They will happen again--perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your in-service training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (www.ismp.org), by calling 800-FAIL-SAFE, or via e-mail at ismpinfo@ismp.org. ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications. [ABSTRACT FROM AUTHOR]

These medication errors have occurred in health care facilities at least once. They will happen again-perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (, by calling 800-FAIL-SAFE, or via e-mail at . ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications. [ABSTRACT FROM AUTHOR]

BD Alaris Pump shut off... Error-prone abbreviations [ABSTRACT FROM AUTHOR]

Inapropriate automatic dispensing cabinet overrides... Pediatric strength Biktarvy accidentally prescribed and dispensed to adults. [ABSTRACT FROM AUTHOR]

Rotarix cap choking hazard... Etoposide vial in DOXOrubicin carton [ABSTRACT FROM AUTHOR]

Prefilled glass syringe incompatible with certain needle-free connectors... QuVa Pharma 2-sided labels for I.V. bags [ABSTRACT FROM AUTHOR]

Understanding the concentration of VIGIV for mpox [ABSTRACT FROM AUTHOR]

These medication errors have occurred in health care facilities at least once. They will happen again-perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (), by calling 800-FAIL-SAFE, or via e-mail at . ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications. [ABSTRACT FROM AUTHOR]

These medication errors have occurred in health care facilities at least once. They will happen again-perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (), by calling 800-FAIL-SAFE, or via e-mail at . ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications. [ABSTRACT FROM AUTHOR]

The article discusses the medication errors reporting program implemented by the Institute for Safe Medication Practices (ISMP). Suggestions are also offered for organizational learning which include increasing staff perception of risk, reducing autonomy and making communicating risk easier. Also tackled are at-risk behaviors by practitioners.

These medication errors have occurred in health care facilities at least once. They will happen again-perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (), by calling 800-FAIL-SAFE, or via e-mail at . ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications. [ABSTRACT FROM AUTHOR]

These medication errors have occurred in health care facilities at least once. They will happen again-perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (), by calling 800-FAIL-SAFE, or via e-mail at . ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications. [ABSTRACT FROM AUTHOR]

These medication errors have occurred in health care facilities at least once. They will happen again-perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (), by calling 800-FAIL-SAFE, or via e-mail at . ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications. [ABSTRACT FROM AUTHOR]

These medication errors have occurred in health care facilities at least once. They will happen again-perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (), by calling 800-FAIL-SAFE, or via e-mail at . ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications. [ABSTRACT FROM AUTHOR]

These medication errors have occurred in health care facilities at least once. They will happen again—perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (www.ismp.org), by calling 800-FAIL-SAFE, or via e-mail at ismpinfo@ismp.org. ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications. [ABSTRACT FROM AUTHOR]

The article presents Institute for Safe Medication Practices (ISMP) medication error report, which shows vulnerabilities in the surgery like container mix-ups and syringe swaps. Topics include medication errors in the perioperative area, selection of the prepared syringe for administration, and cases of mix-ups between tranexamic acid and bupivacaine drugs.

The article discusses potential medication errors like mix-up between drugs being administered in the treatment of cancer. Topics discussed include preventive measures such as alertness of personnel and procedural safeguards, use of methylene blue as a monoamine oxidase inhibitor which can interact with serotonergic drugs, and the most common toxic effects of a low-dose methotrexate such as gastrointestinal and hematological.

The article offers information on reports on medical errors presented by Institute For Safe Medication Practices (ISMP). It mentions the difference in drug formulation of cycloSPORINE capsules and oral solution known by Sandimmune and Gengraf. The medical error of overdose of CycloSPORINE in a transplant recipient is reported and the dosages of immunosuppressants is also discussed. Gastroesophageal reflux drug AcipHex Sprinkle RABEprazole sodium that shouldn't be swallowed whole is offered.

The article presents an analysis of Institute for Safe Medication Practices (ISMP) error report. It is said that plans are underway at medical centers to give pharmacists authority to dispense pen needles without a prescription whenever insulin pens are prescribed. It also refers to the case a patient with atrial fibrillation admitted to a hospital for insertion of a left atrial appendage device, where hospital staff entered VESIcare (solifenacin) instead of the intended product, Vessel Care.

No expiration date on COVID-19 vaccine label... STS abbreviation results in a close call... [ABSTRACT FROM AUTHOR]

Confirm tenecteplase indication and dose before use... PDMPs can identify duplicate opioid therapy [ABSTRACT FROM AUTHOR]

COVID-19 vaccine package concerns... Potassium chloride for injection concentrate 250 mL bags reaching organizations... Pharmacists can now prescribe Paxlovid but should be aware of error risks [ABSTRACT FROM AUTHOR]

The article presents a medication error report analysis from the Institute for Safe Medication Practices (ISMP) and the U.S. Food and Drug Administration (FDA). Information about the use of tissue plasminogen activator activase in acute myocardial infarction management, is provided. Also emphasized is the effect of wrong drug errors in cardiac patients.

The article discusses the report through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program on medication error in health care facilities and which can be avoided through education and alertness of personnel and procedural safeguards. It suggest that healthcare facilities must consider publishing accounts of errors in their newsletters or presenting them at their in-service training programs.

These medication errors have occurred in health care facilities at least once. They will happen again-perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (www.ismp.org), by calling 800-FAIL-SAFE, or via e-mail at ismpinfo@ismp.org. ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications. [ABSTRACT FROM AUTHOR]

These medication errors have occurred in health care facilities at least once. They will happen again--perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs. [ABSTRACT FROM AUTHOR]

The article discusses several reports of medication errors that were received through the Medication Errors Reporting Program of the U.S. Institute for Safe Medication Practices. Topics include wrong route errors in the administration of epinephrine such as intravenous instead of intramuscular, the proper use of epinephrine for the treatment of an anaphylactic reaction, and errors related to the use of PRADAXA (dabigatran etexilate) capsules, which should not be opened before administration.

AuroMedics etomidate, pantoprazole, and bupivacaine mix-ups... Topical gel dispensed in an ENFit syringe given via G-tube [ABSTRACT FROM AUTHOR]

Paxlovid drug interaction... Eprontia oral solution concentration conversion... Different concentrations of oral liquid Baclofen [ABSTRACT FROM AUTHOR]

AuroMedics etomidate, pantoprazole, and bupivacaine mix-ups...Topical gel dispensed in an ENFit syringe given via G-tube [ABSTRACT FROM AUTHOR]

These medication errors have occurred in health care facilities at least once. They will happen again-perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMPWeb site (), by calling 800-FAIL-SAFE, or via e-mail at . ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications. [ABSTRACT FROM AUTHOR]

These medication errors have occurred in health care facilities at least once. They will happen again-perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your news-letters and/or presenting them at your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (), by calling 800-FAIL-SAFE, or via e-mail at . ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications. [ABSTRACT FROM AUTHOR]

These medication errors have occurred in health care facilities at least once. They will happen again-perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your news-letters and/or presenting them at your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (www.ismp.org), by calling 800-FAIL-SAFE, or via e-mail at ismpinfo@ismp.org. ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications. [ABSTRACT FROM AUTHOR]

The article discusses the measures taken by the U.S. and European regulators in managing the safety problems associated with anticoagulant dabigatran. Topics discussed include the U.S. Food and Drug Administration's marketing approval to dabigatran in 2010 after completing its own pharmacokinetic and pharmacodynamic modelling, the European Medicines Agency's emphasis on measures to minimize bleeding risks of dabigatran, and risks and benefits of 110 milligram dabigatran dose.